Pilot Study Investigating the Use of the ReBuilder to Treat Chemotherapy Induced Peripheral Neuropathy in Patients With Breast Cancer

Inclusion Criteria:

Patients with breast cancer referred to Physical Therapy for CIPN
Physical Therapy Examination indicates use of Rebuilder for CIPN
At least 18 years of age
Signed informed consent for study population
Willingness to complete study according to protocol

Exclusion Criteria:

Patients who do not have CIPN
Patients <18 years of age
Inability to or unwilling to sign informed consent
Unable to read and understand the English language
Preexisting sensory peripheral neuropathy from other comorbid conditions such as diabetes or alcoholism
More than three (3) prior ReBuilder treatments; OR ReBuilder within the last 30 days, for sensory peripheral neuropathy